Mark A. Jones, PhD; Rokuro Hama, MD; Chris Del Mar, MD
Potential Conflicts of Interest: Dr. Jones: Other: unpaid investigator on a UK National Institute for Health Research grant for a systematic review of neuraminidase inhibitors. Dr. Hama: Expert testimony (unpaid): provided scientific opinions on 11 adverse reaction cases related to oseltamivir following application by families for adverse reaction compensation; however, received no money for 8 cases and during the 82 months prior to submission; Royalties: books published by Kin-yobi Co Ltd and Japan Institute of Pharmacovigilence; Other: paid investigator on a UK National Institute for Health Research grant for a systematic review of neuraminidase inhibitors. Dr. Del Mar: Consultancy: Key Pharmaceuticals (topical ear product), GlaxoSmithKline (vaccine for otitis media); Grants/grants pending (money to institution): National Health and Medical Research Council (Australia), UK National Institute for Health Research; Royalties: books published by Elsevier and BMJ; Travel/accommodations/meeting expenses unrelated to activities listed: travel to Taiwan for an international conference on viral illness in March 2010; Other: Coordinating Editor of the Acute Respiratory Infections Group of the Cochrane Collaboration.
Jones MA, Hama R, Del Mar C. Antivirals for Treatment of Influenza. Ann Intern Med. 2012;157:385. doi: 10.7326/0003-4819-157-5-201209040-00016
Download citation file:
Published: Ann Intern Med. 2012;157(5):385.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use